RxDoctor Payments Data

Paul Araullo

Psychiatric/Mental Health · Compton, CANPI 1053744870

Payments from drug & device makers

$6,723in general payments, 2019–2025

Across 241 payments — averaging $27.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Johnson & Johnson$733
  • AbbVie$666
  • Neurocrine Biosciences, Inc.$387
  • plus $499 from 6 others

What the payments were for

  • Food & beverage$6,65999%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,723 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine34$212,542
AristadaAripiprazole Lauroxil49$143,147
LybalviOlanzapine/Samidorphan Malate78$124,998
Abilify MaintenaAripiprazole34$93,994
VraylarCariprazine Hcl58$86,216
RexultiBrexpiprazole54$85,181
PerserisRisperidone31$84,353
Invega SustennaPaliperidone Palmitate29$82,675
CaplytaLumateperone Tosylate49$81,087
Lurasidone Hcl175$36,554
VivitrolNaltrexone Microspheres15$23,968
Clozapine212$17,302
Chlorpromazine Hcl124$16,000
Fluvoxamine Maleate192$8,106
Quetiapine Fumarate520$8,077

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada, Lybalvi, Vivitrol$2,073$292,112142 claims
Teva Pharmaceuticals USA, Inc.Austedo$56$212,54234 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$1,057$179,17488 claims
AbbVieVraylar$666$86,21658 claims
Indivior Inc.Perseris$212$84,35331 claims
Johnson & JohnsonInvega Sustenna$733$82,67529 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,308$81,08749 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Compton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →